XTANDI QUICK START+® Program

The XTANDI QUICK START+® Program provides a one-time, 14-day supply of XTANDI® (enzalutamide) at no cost to new patients who experience a delay in insurance coverage.

  • Patient eligibility for the QuickStart+ Program includes:
    • Be new to XTANDI therapy
    • Have experienced an insurance-related access delay
    • Have been prescribed XTANDI for an FDA-approved indication
  • Allow patients to start their XTANDI treatment while XTANDI Support Solutions®a or a network specialty pharmacy works with the patient's insurer to resolve coverage issues
  • Offers overnight shipping directly to the patient

a XTANDI Support Solutions is a component of Astellas Pharma Support SolutionsSM.

QUICK START+® is a registered trademark of Astellas US LLC.